21 CFR § 520.2475Chapter I

§ 520.2475 Toceranib.

Primary source

Verbatim text below is from the Electronic Code of Federal Regulations (eCFR), a public-domain U.S. government work. Always verify the current version with the eCFR before relying on it for any legal matter.

Full Text

Specifications.(a) Each tablet contains 10, 15, or 50 milligrams (mg) toceranib as toceranib phosphate.

Sponsor.(b) See No. 054771 in § 510.600 of this chapter.

Conditions of useDogsAmount.(c) —(1) —(i) Administer an initial dose of 3.25 mg per kilogram (1.48 mg per pound) body weight, orally every other day.

Indications for use.(ii) For the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement.

Limitations.(iii) Federal law restricts this drug to use by or on the order of a licensed veterinarian.

(2) [Reserved]

[74 FR 28875, June 18, 2009, as amended at 79 FR 28832, May 20, 2014]

eCFR data current as of: June 10, 2026

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.